Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12318446 | Reducing side effects of immunotherapy using genetically modified hematopoietic cells | Michael Lutteropp, Andrew Kaiser, Mario Assenmacher, Stefan Miltenyi | 2025-06-03 |
| 12246065 | Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen | Michael Lutteropp, Andrew Kaiser, Mario Assenmacher, Stefan Miltenyi | 2025-03-11 |
| 12181475 | Reagents for detection of chimeric antigen receptor cells | Michaela Niemöller, Jonathan Fauerbach, Christian Dose, Tina Borke | 2024-12-31 |
| 11883494 | Combination of immune effector cells specific for a target antigen and hematopoietic calls that express the target antigen in an altered form | Michael Lutteropp, Andrew Kaiser, Mario Assenmacher, Stefan Miltenyi | 2024-01-30 |
| 11419935 | Immunotherapy method comprising administering a combination of immune effector cells and non-target hematopoietic cells | Michael Lutteropp, Andrew Kaiser, Mario Assenmacher, Stefan Miltenyi | 2022-08-23 |
| 11033619 | Combination of immune effector cells specific for a target antigen and hematopoietic cells that express the target antigen in an altered form | Michael Lutteropp, Andrew Kaiser, Mario Assenmacher, Stefan Miltenyi | 2021-06-15 |
| 10871490 | Assay for detection of chimeric antigen receptor T cells | Michaela Niemöller, Volker Nolle, Stefan Miltenyi, Mario Assenmacher | 2020-12-22 |
| 10201606 | Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases | Michael Lutteropp, Andrew Kaiser, Mario Assenmacher, Stefan Miltenyi | 2019-02-12 |